NCT02217631View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 653048 BS H3PO4 Capsule Multiple Rising Doses in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

March 31, 2010

Conditions
Healthy
Interventions
DRUG

BI 653048 BS H3PO4

DRUG

Prednisolone low dose

DRUG

Prednisolone high dose

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY